ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes

Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorScripps Whittier Diabetes Institute

About this trial

This research will compare a psychological intervention ("ACT1VATE") versus diabetes self-management education and support (DSME/S; usual care) in improving clinical, behavioral, psychosocial, process, and cost outcomes among adults with poorly controlled type 1 diabetes (T1D) who are experiencing significant diabetes-related emotional distress and poor glycemic control in a real world, healthcare environment.

Eligibility criteria

Qualifiers

Spanish or English-speaking

Type 1 diabetes

Glycosylated Hemoglobin (HbA1c) 7.0% - 12.5% in last 90 days

Screen positive for diabetes distress

Disqualifiers

Severe medical or psychological conditions that would interfere with participation based on the opinion of a provider

Plans to move out of the San Diego area in the next 12 months

Lack of technology capability required to complete online surveys and telemedicine visit

Trial design

Treatments tested in this trial

  • ACT1VATE
  • DSME/S

Treatment groups

250 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Scripps Whittier Diabetes Institute

Lead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator